Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries.

Hyde-DeRuyscher R, Paige LA, Christensen DJ, Hyde-DeRuyscher N, Lim A, Fredericks ZL, Kranz J, Gallant P, Zhang J, Rocklage SM, Fowlkes DM, Wendler PA, Hamilton PT.

Chem Biol. 2000 Jan;7(1):17-25.

2.

Comparative analyses of mechanistic differences among antiestrogens.

Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP.

Endocrinology. 1999 Dec;140(12):5828-40.

PMID:
10579349
3.

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP.

Science. 1999 Jul 30;285(5428):744-6.

4.

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

Paige LA, Christensen DJ, Grøn H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3999-4004.

5.

Identification of novel human WW domain-containing proteins by cloning of ligand targets.

Pirozzi G, McConnell SJ, Uveges AJ, Carter JM, Sparks AB, Kay BK, Fowlkes DM.

J Biol Chem. 1997 Jun 6;272(23):14611-6.

6.

Yeast alpha mating factor structure-activity relationship derived from genetically selected peptide agonists and antagonists of Ste2p.

Manfredi JP, Klein C, Herrero JJ, Byrd DR, Trueheart J, Wiesler WT, Fowlkes DM, Broach JR.

Mol Cell Biol. 1996 Sep;16(9):4700-9.

7.

Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.

Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DM, Kay BK.

Nat Biotechnol. 1996 Jun;14(6):741-4.

PMID:
9630982
8.

Construction and screening of M13 phage libraries displaying long random peptides.

McConnell SJ, Uveges AJ, Fowlkes DM, Spinella DG.

Mol Divers. 1996 May;1(3):165-76.

PMID:
9237207
9.

Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.

Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK.

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1540-4.

10.

An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets.

Kay BK, Adey NB, He YS, Manfredi JP, Mataragnon AH, Fowlkes DM.

Gene. 1993 Jun 15;128(1):59-65.

PMID:
8508960
11.

Analysis of the heterogeneity of the biological responses to native and mutant human interleukin-6.

Krakauer T, Snouwaert JN, Fowlkes DM, Krakauer H.

J Leukoc Biol. 1992 Oct;52(4):415-20.

PMID:
1328443
12.

Multipurpose vectors for peptide expression on the M13 viral surface.

Fowlkes DM, Adams MD, Fowler VA, Kay BK.

Biotechniques. 1992 Sep;13(3):422-8.

PMID:
1389174
13.

Structural comparisons of meizothrombin and its precursor prothrombin in the presence or absence of procoagulant membranes.

Pei G, Laue TM, Aulabaugh A, Fowlkes DM, Lentz BR.

Biochemistry. 1992 Aug 4;31(30):6990-6.

PMID:
1637833
14.

Identification of a receptor binding site in the carboxyl terminus of human interleukin-6.

Leebeek FW, Kariya K, Schwabe M, Fowlkes DM.

J Biol Chem. 1992 Jul 25;267(21):14832-8.

16.

Role of disulfide bonds in biologic activity of human interleukin-6.

Snouwaert JN, Leebeek FW, Fowlkes DM.

J Biol Chem. 1991 Dec 5;266(34):23097-102.

17.

Analysis of centromere function in Saccharomyces cerevisiae using synthetic centromere mutants.

Murphy MR, Fowlkes DM, Fitzgerald-Hayes M.

Chromosoma. 1991 Dec;101(3):189-97.

PMID:
1790732
18.

The varying frequencies of five DNA polymorphisms of X-linked coagulant factor IX in eight ethnic groups.

Graham JB, Kunkel GR, Egilmez NK, Wallmark A, Fowlkes DM, Lord ST.

Am J Hum Genet. 1991 Sep;49(3):537-44.

19.

Expression, isolation, and characterization of an active site (serine 528----alanine) mutant of recombinant bovine prothrombin.

Pei G, Baker K, Emfinger SM, Fowlkes DM, Lentz BR.

J Biol Chem. 1991 May 25;266(15):9598-604.

20.

AccI polymorphism in von Willebrand factor (F8VWF) at codon 516.

Kunkel GR, Graham JB, Fowlkes DM, Lord ST.

Nucleic Acids Res. 1991 Apr 11;19(7):1729. No abstract available.

21.

Effects of site-specific mutations on biologic activities of recombinant human IL-6.

Snouwaert JN, Kariya K, Fowlkes DM.

J Immunol. 1991 Jan 15;146(2):585-91.

PMID:
1987278
22.

The utility of a HindIII polymorphism of factor VIII examined by rapid DNA analysis.

Graham JB, Kunkel GR, Fowlkes DM, Lord ST.

Br J Haematol. 1990 Sep;76(1):75-9.

PMID:
1977469
23.

RsaI polymorphism in von Willebrand factor (vWF) at codon 789.

Kunkel GR, Graham JB, Fowlkes DM, Lord ST.

Nucleic Acids Res. 1990 Aug 25;18(16):4961. No abstract available.

24.

Irreproducible results.

Fowlkes DM.

Clin Chem. 1990 Jul;36(7):1385. No abstract available.

25.

Functional dissection of adenovirus VAI RNA.

Furtado MR, Subramanian S, Bhat RA, Fowlkes DM, Safer B, Thimmappaya B.

J Virol. 1989 Aug;63(8):3423-34.

26.

Development of a vector system for the expression of bioengineered proteins.

Snouwaert JN, Jambou RC, Skonier JE, Earnhardt K, Stebbins JR, Fowlkes DM.

Clin Chem. 1989 Jul;35(7 Suppl):B7-12.

PMID:
2663236
27.

Convenient uses of polymerase chain reaction in analyzing recombinant cDNA clones.

Nishikawa BK, Fowlkes DM, Kay BK.

Biotechniques. 1989 Jul-Aug;7(7):730-5.

PMID:
2534353
28.

The Malmö polymorphism of factor IX: establishing the genotypes by rapid analysis of DNA.

Graham JB, Kunkel GR, Tennyson GS, Lord ST, Fowlkes DM.

Blood. 1989 Jun;73(8):2104-7.

PMID:
2567187
30.

High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein.

Jambou RC, Snouwaert JN, Bishop GA, Stebbins JR, Frelinger JA, Fowlkes DM.

Proc Natl Acad Sci U S A. 1988 Dec;85(24):9426-30. Erratum in: Proc Natl Acad Sci U S A 1990 Jun;87(12):4894.

31.
32.
33.

A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase.

Nordeen SK, Green PP 3rd, Fowlkes DM.

DNA. 1987 Apr;6(2):173-8.

PMID:
3472867
34.

Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss?

Crabtree GR, Comeau CM, Fowlkes DM, Fornace AJ Jr, Malley JD, Kant JA.

J Mol Biol. 1985 Sep 5;185(1):1-19.

PMID:
4046033
35.

Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions.

Fowlkes DM, Mullis NT, Comeau CM, Crabtree GR.

Proc Natl Acad Sci U S A. 1984 Apr;81(8):2313-6.

36.

Regulation and characterization of the mRNAs for the A alpha, B beta and gamma chains of fibrinogen.

Crabtree GR, Kant JA, Fornace AJ Jr, Rauch CA, Fowlkes DM.

Ann N Y Acad Sci. 1983 Jun 27;408:457-68. No abstract available.

PMID:
6575701
37.

Transcriptional control regions of the adenovirus VAI RNA gene.

Fowlkes DM, Shenk T.

Cell. 1980 Nov;22(2 Pt 2):405-13.

PMID:
7448868
38.

Interaction between the adenovirus DNA-binding protein and double-stranded DNA.

Fowlkes DM, Lord ST, Linné T, Pettersson U, Philipson L.

J Mol Biol. 1979 Aug 5;132(2):163-80. No abstract available.

PMID:
231660
39.

T-mycoplasmas and human infertility: correlation of infection with alterations in seminal parameters.

Fowlkes DM, MacLeod J, O'Leary WM.

Fertil Steril. 1975 Dec;26(12):1212-8.

PMID:
803036
40.

Supplemental Content

Loading ...
Support Center